Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470897 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT02470897 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 115 participants.
The verdict
NCT02470897, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
This phase I/II trial studies the side effects and best dose of stereotactic body radiation therapy while using intensity-modulated radiation therapy (IMRT) planning to help avoid radiation to normal tissue in patients with prostate cancer. Stereotactic body radiation therapy is a specialized radiation therapy that sends x-rays directly to the tumor using small, high doses of radiation over several days and may cause less damage to normal tissue. This treatment schedule allows for a higher dose of radiation to be administered over a shorter overall treatment period in comparison to standard radiation therapy.
Interventions
- RADIATION SBRT
- RADIATION Radiation Therapy Treatment Planning and Simulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2015-07-24 |
| Est. Completion | 2025-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470897
The ClinicalTrials.gov registry entry for NCT02470897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SBRT is the first listed.
NCT02470897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470897 about?
NCT02470897 is a clinical study titled "Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer". This phase I/II trial studies the side effects and best dose of stereotactic body radiation therapy while using intensity-modulated radiation therapy (IMRT) planning to help avoid radiation to normal tissue in patients with prostate cancer. Stereotactic body radiation therapy is a specialized radiat...
What is the current status of trial NCT02470897?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2015-07-24. Estimated completion is 2025-08-18.
What interventions are being tested in trial NCT02470897?
The interventions under investigation include: SBRT (RADIATION), Radiation Therapy Treatment Planning and Simulation (RADIATION).
Who is sponsoring clinical trial NCT02470897?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.